A detailed history of Fmr LLC transactions in Biogen Inc. stock. As of the latest transaction made, Fmr LLC holds 610,416 shares of BIIB stock, worth $121 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
610,416
Previous 620,850 1.68%
Holding current value
$121 Million
Previous $134 Million 5.7%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $1.99 Million - $2.47 Million
-10,434 Reduced 1.68%
610,416 $142 Million
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $80.6 Million - $102 Million
-380,294 Reduced 37.99%
620,850 $134 Million
Q4 2023

Feb 13, 2024

SELL
$222.59 - $267.94 $80.1 Million - $96.4 Million
-359,907 Reduced 26.44%
1,001,144 $259 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $324 Million - $366 Million
-1,279,470 Reduced 48.46%
1,361,051 $350 Million
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $244 Million - $282 Million
887,907 Added 50.66%
2,640,521 $752 Million
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $139 Million - $158 Million
541,421 Added 44.7%
1,752,614 $487 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $66.9 Million - $81.3 Million
-265,039 Reduced 17.95%
1,211,193 $335 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $87.6 Million - $121 Million
450,066 Added 43.86%
1,476,232 $394 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $120 Million - $142 Million
638,196 Added 164.5%
1,026,166 $209 Million
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $38.9 Million - $49 Million
200,669 Added 107.14%
387,970 $81.7 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $222 Million - $285 Million
-990,252 Reduced 84.09%
187,301 $44.9 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $49.4 Million - $64.5 Million
-174,665 Reduced 12.92%
1,177,553 $333 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $350 Million - $561 Million
1,352,218 New
1,352,218 $468 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $28.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.